Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FWFBN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,335
Award facts
- Contract value 100% obligated
- $2,335.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,335.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 11, 2025, for TYMLOS 80 mcg dose pen injector (1.56mL). The delivery order, which must be completed by July 14, 2025, does not utilize a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which authorizes the agency to issue firm fixed-price orders for pharmaceutical items supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain, specializing in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities. The company's contract portfolio demonstrates consistent success in competing for federal pharmaceutical procurement without set-aside restrictions. TYMLOS (abaloparatide) is an injectable medication used for osteoporosis treatment, reflecting DLA's procurement of specialty pharmaceuticals across therapeutic categories to support military medical operations globally.
Quick answers
Who was awarded contract SPE2DB25FWFBN?
SPE2DB25FWFBN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 11, 2025.
How much is contract SPE2DB25FWFBN worth?
The government has obligated $2,335 on SPE2DB25FWFBN.
Is contract SPE2DB25FWFBN an order under another contract?
Yes. SPE2DB25FWFBN is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB25FWFBN competed?
The extent of competition for SPE2DB25FWFBN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award